Procan and Bronchospasm - a phase IV clinical study of FDA data
Summary:
We study 18,805 people who take Procan (procainamide hydrochloride) or have Bronchospasm. No report of Bronchospasm is found in people who take Procan.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Procan?
Procan has active ingredients of procainamide hydrochloride. eHealthMe is studying from 183 Procan users. Check the latest studies of Procan.
What is Bronchospasm?
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi) is found to be associated with 1,123 drugs and 1,099 conditions by eHealthMe. Check the latest studies of Bronchospasm.
No report is found.
Do you take Procan and have Bronchospasm?
- Check whether Bronchospasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Procan:
- Procan (183 reports)
Bronchospasm treatments and more:
- Bronchospasm (18,622 reports)
How severe was Bronchospasm and when was it recovered:
Expand to all the drugs that have ingredients of procainamide hydrochloride:
Browse all side effects of Procan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Bronchospasm:
Browse all the conditions that are associated with Bronchospasm:
How the study uses the data?
The study uses data from the FDA. It is based on procainamide hydrochloride (the active ingredients of Procan) and Procan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Primary Progressive Multiple Sclerosis and Paraesthesia - 3 seconds ago
- Drug interactions of Sprintec and Omeprazole - 7 seconds ago
- Could Vesicare cause Sinus Disorder? - 9 seconds ago
- Drug interactions of Amaryl and Loratadine - 17 seconds ago
- Could Simvastatin cause Prostatic Specific Antigen Increased? - 23 seconds ago
- Could Lantus Solostar cause Scratch? - 42 seconds ago
- Drug interactions of Fludara and Caspofungin Acetate - 55 seconds ago
- Drug interactions of Fentanyl and Carpine - a minute ago
- Drug interactions of Kyprolis and Clopidogrel - a minute ago
- Could Valcyte cause Bk Virus Infection? - a minute ago